0001209191-16-115686.txt : 20160426
0001209191-16-115686.hdr.sgml : 20160426
20160426160625
ACCESSION NUMBER: 0001209191-16-115686
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160425
FILED AS OF DATE: 20160426
DATE AS OF CHANGE: 20160426
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
CENTRAL INDEX KEY: 0001299130
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 161590339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1380 WILLOW ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-521-8000
MAIL ADDRESS:
STREET 1: 1380 WILLOW ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC
DATE OF NAME CHANGE: 20050829
FORMER COMPANY:
FORMER CONFORMED NAME: NANOFLUIDICS INC
DATE OF NAME CHANGE: 20040729
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Phillips James Michael
CENTRAL INDEX KEY: 0001504238
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34899
FILM NUMBER: 161592072
MAIL ADDRESS:
STREET 1: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
STREET 2: 1380 WILLOW ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-04-25
0
0001299130
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PACB
0001504238
Phillips James Michael
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
1380 WILLOW ROAD
MENLO PARK
CA
94025
0
1
0
0
SVP, Research & Development
Common Stock
2016-04-25
4
M
0
20000
1.96
A
201449
D
Common Stock
2016-04-25
4
S
0
20000
10.286
D
181449
D
Stock Option (right to buy)
1.96
2016-04-25
4
M
0
20000
0.00
D
2017-06-21
Common Stock
20000
17500
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
This is the weighted average price of the shares sold, which ranged from $10.02 to $10.61 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
100% of the shares subject to the option are fully vested and exercisable.
James Michael Phillips
2016-04-26